Blood Products Market Global Industry Analyses 2016-2020 an opportunity forecasted 2020-2030
Market Overview
Any component or portion of blood that is harvested from a donor for use in patients is referred to as a blood product. Not every patient requires complete blood transfusion; many simply require transfusion of certain blood components. Several blood components are isolated from the total blood in such circumstances. Platelets, red blood cells (RBCs), white blood cells (WBCs), fresh frozen plasma (FFP), clotting factors, and other blood products are among the blood products available. An individual is given a specific blood product depending on their condition. Blood is an extremely important bodily fluid that ensures the proper functioning of organs. However, there are a variety of chronic medical problems that cause the body's red blood cell count to drop. Diseases like leukemia, cancer, and end-stage renal disease, for example, cause significant consequences that necessitate blood transfusions.
Blood Products Market: Key Players
Abbott Laboratories
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
American Red Cross
America`s Blood Centers
BPL Inc.
CSL
Mitsubishi Tanabe Pharma Corporation
Bharat Serums and Vaccines Ltd.
Bio Products Laboratory Ltd.
Kedrion S.p.A
Bio-Rad Laboratories, Inc.
Octapharma AG
Canadian Blood Services
Growth Factor
Rise in geriatric population
According to the World Health Organization, the worldwide population of people aged 60 and over will nearly double from 12 percent to 22 percent between 2015 and 2050, with 80 percent of the aging population residing in low- and middle-income nations. The world's ageing population may result in a rise in illnesses that require plasma treatment. As a result, the market will develop faster as the senior population grows.
Segmentation
By Product Type
Platelets
Fresh Frozen Plasma (FFP)
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Others
By End-User
Hospitals
Blood Station
Others
Blood Products Market Dynamics
Blood Products Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Recent News Related to Market
North America is the market leader for blood plasma products, accounting for 44.2 percent of the market in 2018. This is owing to the increased prevalence of hemophilia and the FDA's quick approval of plasma products.
In October 2018, The FDA revised its criteria on dried plasma products for blood transfusion, including everything from the best sources of input plasma to device submissions.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Blood Products Market growth?
Which segment accounted for the largest Blood Products Market share?
Who are the key players in the Blood Products Market?
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Any component or portion of blood that is harvested from a donor for use in patients is referred to as a blood product. Not every patient requires complete blood transfusion; many simply require transfusion of certain blood components. Several blood components are isolated from the total blood in such circumstances. Platelets, red blood cells (RBCs), white blood cells (WBCs), fresh frozen plasma (FFP), clotting factors, and other blood products are among the blood products available. An individual is given a specific blood product depending on their condition. Blood is an extremely important bodily fluid that ensures the proper functioning of organs. However, there are a variety of chronic medical problems that cause the body's red blood cell count to drop. Diseases like leukemia, cancer, and end-stage renal disease, for example, cause significant consequences that necessitate blood transfusions.
Blood Products Market: Key Players
Abbott Laboratories
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
American Red Cross
America`s Blood Centers
BPL Inc.
CSL
Mitsubishi Tanabe Pharma Corporation
Bharat Serums and Vaccines Ltd.
Bio Products Laboratory Ltd.
Kedrion S.p.A
Bio-Rad Laboratories, Inc.
Octapharma AG
Canadian Blood Services
Growth Factor
Rise in geriatric population
According to the World Health Organization, the worldwide population of people aged 60 and over will nearly double from 12 percent to 22 percent between 2015 and 2050, with 80 percent of the aging population residing in low- and middle-income nations. The world's ageing population may result in a rise in illnesses that require plasma treatment. As a result, the market will develop faster as the senior population grows.
Segmentation
By Product Type
Platelets
Fresh Frozen Plasma (FFP)
Red Blood Cells (RBCs)
White Blood Cells (WBCs)
Others
By End-User
Hospitals
Blood Station
Others
Blood Products Market Dynamics
Blood Products Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Recent News Related to Market
North America is the market leader for blood plasma products, accounting for 44.2 percent of the market in 2018. This is owing to the increased prevalence of hemophilia and the FDA's quick approval of plasma products.
In October 2018, The FDA revised its criteria on dried plasma products for blood transfusion, including everything from the best sources of input plasma to device submissions.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Blood Products Market growth?
Which segment accounted for the largest Blood Products Market share?
Who are the key players in the Blood Products Market?
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. EXECUTIVE SUMMARY
2. GLOBAL BLOOD PRODUCTS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL BLOOD PRODUCTS MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL BLOOD PRODUCTS MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL BLOOD PRODUCTS MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Platelets, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Fresh Frozen Plasma (FFP), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Red Blood Cells (RBCs), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. White Blood Cells (WBCs), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End-User: Market Share (2020-2030F)
12.3.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Blood Station, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. American Red Cross
13.3. America`s Blood Centers
13.4. BPL Inc.
13.5. CSL
13.6. Mitsubishi Tanabe Pharma Corporation
13.7. Bharat Serums and Vaccines Ltd.
13.8. Bio Products Laboratory Ltd.
13.9. Kedrion S.p.A
13.10. Bio-Rad Laboratories, Inc.
13.11. Octapharma AG
13.12. Canadian Blood Services
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. GLOBAL BLOOD PRODUCTS MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. GLOBAL BLOOD PRODUCTS MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. GLOBAL BLOOD PRODUCTS MARKET
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. GLOBAL BLOOD PRODUCTS MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product: Market Share (2020-2030F)
12.2.1. Platelets, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Fresh Frozen Plasma (FFP), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Red Blood Cells (RBCs), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.4. White Blood Cells (WBCs), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End-User: Market Share (2020-2030F)
12.3.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Blood Station, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. COMPANY PROFILE
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. American Red Cross
13.3. America`s Blood Centers
13.4. BPL Inc.
13.5. CSL
13.6. Mitsubishi Tanabe Pharma Corporation
13.7. Bharat Serums and Vaccines Ltd.
13.8. Bio Products Laboratory Ltd.
13.9. Kedrion S.p.A
13.10. Bio-Rad Laboratories, Inc.
13.11. Octapharma AG
13.12. Canadian Blood Services
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
